Exchange Announcement • 08 Feb 2022 20:00
Exchange Announcement • 13 Feb 2021 02:42
Exchange Announcement • 02 Jul 2020 15:30
Exchange Announcement • 24 Jun 2020 00:49
Exchange Announcement • 24 Jun 2020 00:49
ENTITY
Progenics Pharmaceuticals (PGNX US)
Progenics Pharmaceuticals (PGNX US)
2
Analysis
Health Care • United States
Progenics Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Progenics' principal programs are directed toward supportive care, virology (human immunodeficiency virus and hepatitis C virus infections), and oncology.
more
x